昊海生物科技：7月未实施A股股份回购

Core Viewpoint - The company, Haohai Biological Technology (06826), announced that it has not implemented an A-share buyback as of July 2025, with a total of 1.8324 million A-shares repurchased, representing 0.79% of the total share capital of 233 million shares [1] Summary by Relevant Sections - Share Buyback Details - The company repurchased a total of 1.8324 million A-shares through centralized bidding, with a maximum transaction price of 63.58 CNY per share and a minimum transaction price of 49.25 CNY per share [1] - The total amount spent on the buyback was 104 million CNY, excluding transaction fees such as stamp duty and commission [1]